Mouse study suggests ageing well is in the blood

Publicly released:
International
Shutterbug75
Shutterbug75

Loss of a specific blood protein has been linked to poorer aging outcomes in an international mouse study. The red blood cell protein ADORA2B is known to help release oxygen from the blood. Researchers bred mice lacking ADORA2B in their blood and monitored them alongside regular mice. As they aged, the mice lacking the blood protein were more likely to develop poorer memory and hearing and develop inflammation in the brain. The researchers say more studies are needed to determine whether treatments to activate ADORA2B could reduce cognitive decline.

Media release

From: PLOS

Anti-aging protein in red blood cells helps stave off cognitive decline

Mice lacking ADORA2B in their blood exhibit accelerated aging, including poor memory and hearing deficits

Research conducted by Qiang et al has discovered a link between a protein in red blood cells and age-related decline in cognitive performance. Published in the open access journal PLOS Biology on 17th June 2021, the study shows that depleting mouse blood of the protein ADORA2B leads to faster declines in memory, delays in auditory processing, and increased inflammation in the brain.

As life expectancies around the world increase, so are the number of people who will experience age-related cognitive decline. Because the amount of oxygen in the blood also declines with age, the team hypothesized that aging in the brain might be naturally held at bay by adenosine receptor A2B (ADORA2B), a protein on the membrane of red blood cells which is known to help release oxygen from the blood cells so it can be used by the body. To test this idea, they created mice that lacked ADORA2B in their blood and compared behavioral and physiological measures with control mice.

The team found that as the mice got older, the hallmarks of cognitive decline—poor memory, hearing deficits, and inflammatory responses in the brain—were all greater in the mice lacking ADORA2B than in the control mice. Additionally, after experiencing a period of oxygen deprivation, the behavioral and physiological effects on young mice without ADORA2B were much greater than those on normal young mice.

Thus, aging in the brain is naturally reduced by ADORA2B, which helps get oxygen to the brain when needed. Further testing will be needed to determine whether ADORA2B levels naturally decline with age and whether treatment with drugs that activate ADORA2B can reduce cognitive decline in normal mice.

Dr. Xia, the leader of the study, commented “Red blood cells have an irreplaceable function to deliver oxygen to maintain bioenergetics of every single cell within our body. However, their function in age-related cognition and hearing function remains largely unknown.  Our findings reveal that the red blood cell ADORA2B signaling cascade combats early onset of age-related decline in cognition, memory and hearing by promoting oxygen delivery in mice and immediately highlight multiple new rejuvenating targets”.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research PLOS, Web page The URL will go live after the embargo ends
Journal/
conference:
PLOS Biology
Research:Paper
Organisation/s: Central South University, China
Funder: This work is supported by National Institutes of Health Grants HL136969S (to YX) and HL136969 (to YX and YZ); McGovern Scholar Funds (to YX); The Bob and Hazel Casey Endowment of University of Texas Health Science Center-McGovern Medical School (to REK); National Institutes of Health Grants HL146442, HL149714, HL148151, HL150032 (to ADA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Media Contact/s
Contact details are only visible to registered journalists.